Activity

Activity Description

The Institute of Medicine will convene an ad hoc committee to describe the long term trajectory for the global AIDS pandemic, why the problem is critically important to the U.S. and international interests and to highly affected countries, the relationship between current capacities and needed capacities, and provide consensus conclusions and recommendations for how the U.S. and other donor countries can innovatively respond to the challenge through institutional and human resource capacity building.

Specific questions to be addressed are:

1. A decade from now (2018) what is the best projection for global incidence and burden of HIV/AIDS and its demographic and geographic distribution? What is the sensitivity of these projections to assumptions concerning the prevention of HIV infection? 

2.  What are the long term human resource and institutional implications of the projected global HIV infection prevalence on U.S. health, economic, diplomatic, industrial, scientific, academic, and other interests? 

3. What are the implications of the projected HIV incidence and overall HIV/AIDS burden from the perspective of African governments and institutions including academia and the health care sector? 

4. What should be the strategies for the U.S. and highly-affected nations to develop now in order to ensure domestic and international capacities for highly effective HIV prevention, treatment, and care efforts in the 2018-2023 timeframe? What structures, systems, and professions would be necessary to implement these strategies? How should South-South and regional considerations be incorporated into national plans?

1. What could be the strategic role of U.S., African, and other universities in highly affected areas with respect to support for “twinning” at the level of individual faculty members, departments, schools, and entire universities?
2. What could be the strategic role of other American institutions in supporting “twinning” for global capacity building relevant to HIV prevention, treatment, and care? What are the pro’s and con’s of these forms of assistance?
3. What should be the role of African science academies in supporting HIV/AIDS prevention, treatment, and care strategy refinements at the national level?

5.  What are the implications of the projected HIV incidence and burden of HIV/AIDS for the capacity of resource-constrained countries to conduct decision making in an ethical manner?